Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Cancer Journal (Sudbury, Mass.)|May 8, 2004
Novel systemic therapy options for hepatocellular carcinomaMike Cusnir, Yehuda Z PattHuman Vaccines & Immunotherapeutics|August 3, 2012
Inter-tumor heterogeneityMike Cusnir, Ludmila CavalcanteJournal of Clinical Gastroenterology|August 23, 2002
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United StatesManal M Hassan, Adam Frome, Yehuda Z Patt, et al.Clinical Advances in Hematology & Oncology : H&O|May 28, 2024
Improving survival in metastatic colorectal cancer through optimized patient selectionTanios S Bekaii-Saab, Afsaneh Barzi, Mike CusnirCase Reports in Oncology|February 1, 2012
Typical bronchial carcinoid metastasizing to the brain: a case presentationSimon B Zeichner, Mike Cusnir, Michael Francavilla, et al.Case Reports in Oncological Medicine|May 11, 2013
Gastric small-cell carcinoma found on esophagogastroduodenoscopy: a case report and literature reviewNatassja Frances, Simon B Zeichner, Michael Francavilla, et al.Clinical Medicine Insights. Oncology|November 2, 2012
A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature ReviewSimon B Zeichner, Naveen Raj, Mike Cusnir, et al.Liver Cancer|May 29, 2015
Treatment of hepatocellular carcinoma in the community: disparities in standard therapyLinda C Harlan, Helen M Parsons, Charles L Wiggins, et al.Journal of Investigative Medicine High Impact Case Reports|October 30, 2016
An Occult Malignancy Behind a Demyelinating Disease: POEMS SyndromeSaberio Lo Presti, Prashanth Kanagarajah, Daniela Pirela, et al.Pathology, Research and Practice|August 23, 2020
Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomasKritika Krishnamurthy, Mike Cusnir, Michael Schwartz, et al.Pageof 5